Hospital
Decatur Memorial Hospital
Decatur Memorial Hospital was paid $2.27M by Medicaid between Jan 2018 and Feb 2024, across 105 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 68% of everything it billed.
33Billing provider infoDECATUR MEMORIAL HOSPITAL
DECATUR, IL 62526
DECATUR, IL 62526
33aNPI1942352273assigned 01/17/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.27M
24GClaims93,204
24DCodes billed105
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#18 of 129
Median peer was paid$547K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,230 | $752K | |
| 2019 | 48,367 | $1.14M | |
| 2020 | 17,355 | $373K | |
| 2024incomplete | 252 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 68% | 16,223 | 3,510 | $1.55M |
| 97161 | 8.0% | 1,808 | 1,561 | $181K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.0% | 1,097 | 1,068 | $68K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 2,171 | 591 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 3,978 | 3,699 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 1,615 | 1,330 | $26K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 1,611 | 1,325 | $25K |
| 90686 | 1.1% | 1,695 | 543 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 2,411 | 1,100 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,118 | 2,805 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 5,098 | 4,478 | $18K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,775 | 1,610 | $18K |
93 more codes
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 368 | $16K |
| 73630 | <1% | 1,366 | $14K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 509 | $14K |
| 92567 | <1% | 872 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,906 | $13K |
| 73610 | <1% | 774 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,083 | $11K |
| 73564 | <1% | 883 | $11K | |
| 92504 | <1% | 288 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,764 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,398 | $8K |
| G0008 | Administration of influenza virus vaccine | <1% | 1,456 | $8K |
| 72100 | <1% | 568 | $7K | |
| 92557 | <1% | 182 | $7K | |
| 74018 | <1% | 635 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 217 | $6K |
| 80061 | Lipid panel | <1% | 2,607 | $5K |
| 92555 | <1% | 305 | $4K | |
| 73130 | <1% | 530 | $4K | |
| 73030 | <1% | 350 | $4K | |
| 73110 | <1% | 341 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,604 | $3K |
| 80306 | <1% | 750 | $3K | |
| 84439 | <1% | 1,182 | $3K | |
| 97165 | <1% | 81 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 269 | $3K |
| 73502 | <1% | 160 | $3K | |
| 85610 | <1% | 1,882 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 794 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 808 | $2K |
| 81003 | <1% | 2,885 | $2K | |
| 87186 | <1% | 552 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,852 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 111 | $2K |
| 87088 | <1% | 439 | $1K | |
| 97162 | <1% | 13 | $1K | |
| 80069 | <1% | 420 | $1K | |
| 82607 | <1% | 364 | $1K | |
| 82728 | <1% | 620 | $1K | |
| 81001 | <1% | 1,550 | $1K | |
| 86038 | <1% | 203 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 44 | $1K |
| 87070 | <1% | 488 | $1K | |
| 82570 | <1% | 641 | $967.08 | |
| 80074 | <1% | 82 | $936.11 | |
| 83970 | <1% | 65 | $909.24 | |
| 84703 | <1% | 294 | $873.57 | |
| 86140 | <1% | 631 | $795.64 | |
| 72050 | <1% | 48 | $754.01 | |
| 86592 | <1% | 610 | $622.68 | |
| 83550 | <1% | 239 | $588.72 | |
| 88142 | <1% | 233 | $561.71 | |
| 81025 | <1% | 579 | $538.93 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 31 | $522.01 |
| 87205 | <1% | 489 | $485.61 | |
| 85652 | <1% | 549 | $416.66 | |
| 85027 | <1% | 239 | $372.40 | |
| 83540 | <1% | 254 | $358.34 | |
| 82043 | <1% | 279 | $333.94 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | $326.62 |
| 86803 | <1% | 53 | $312.17 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 27 | $265.99 |
| 83516 | <1% | 21 | $226.56 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 30 | $223.52 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 29 | $222.56 |
| 85730 | <1% | 110 | $212.29 | |
| 84156 | <1% | 235 | $160.82 | |
| 84403 | <1% | 12 | $160.24 | |
| 86850 | <1% | 112 | $137.90 | |
| 83690 | <1% | 64 | $121.35 | |
| 85018 | <1% | 165 | $116.78 | |
| 73090 | <1% | 20 | $113.87 | |
| 73080 | <1% | 13 | $113.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 55 | $85.59 |
| 80076 | <1% | 33 | $85.58 | |
| 86901 | <1% | 79 | $78.40 | |
| 83735 | <1% | 58 | $76.66 | |
| 72072 | <1% | 12 | $71.38 | |
| 82746 | <1% | 26 | $61.68 | |
| 86900 | <1% | 78 | $56.60 | |
| 82247 | <1% | 24 | $52.21 | |
| 86431 | <1% | 32 | $49.60 | |
| 87147 | <1% | 55 | $44.23 | |
| 84480 | <1% | 13 | $42.38 | |
| 85014 | <1% | 56 | $36.31 | |
| 87081 | <1% | 17 | $22.64 | |
| 84550 | <1% | 14 | $21.51 | |
| 86308 | <1% | 12 | $14.10 | |
| 87340 | <1% | 12 | $13.32 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 30 | $6.80 |
| 99001 | 0% | 120 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 215 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTONE, TIMOTHY (SENIOR VP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Decatur Memorial Hospital | Decatur, IL | $1.10M |
| Decatur Memorial Hospital | Decatur, IL | $666.06 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.